Royal Bank of Canada’s Burning Rock Biotech BNR Stock Holding History

Royal Bank of Canada’s Portfolio BNR Stock Details BNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-2	Closed	–	–	7261
2023 Q1	$0	Hold	2	–	–	﹤0.01%	7080
2022 Q4	$0	Buy	+2	New	+$46	﹤0.01%	7232
2022 Q1	–	Sell	-22	Closed	-$2K	–	7734
2021 Q4	$2K	Buy	22 +21	+2,100%	+$2.88K	﹤0.01%	7388
2021 Q3	$0	Buy	+1	New	+$222	﹤0.01%	7633
2021 Q2	–	Sell	-2	Closed	-$592	–	7482
2021 Q1	$0	Sell	2 -20	-91%	-$6.09K	﹤0.01%	7427
2020 Q4	$5K	Buy	+22	New	+$5.91K	﹤0.01%	6619

Other funds holding BNR

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada's BNR Position: Q2 2023 in Review

Royal Bank of Canada sold out of Burning Rock Biotech (BNR) in Q2 2023, closing a stake of 2 shares.

Royal Bank of Canada first reported a position in BNR in Q4 2020 and held it in 6 quarters. The position peaked at $5K in Q4 2020. 32 funds tracked by Wall St. Rank hold BNR as of Q2 2023.

Royal Bank of Canada reported no remaining Burning Rock Biotech position as of Q2 2023 after selling out during the quarter.
Royal Bank of Canada sold 2 Burning Rock Biotech shares in Q2 2023.
Royal Bank of Canada first reported a position in Burning Rock Biotech in Q4 2020 and held it in 6 quarters.
Royal Bank of Canada's Burning Rock Biotech position peaked at $5K in Q4 2020.
32 funds tracked by Wall St. Rank held Burning Rock Biotech as of Q2 2023.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.